Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - P/B ratio
P/B ratio as of April 2024 : 13.7
According to Prometheus Biosciences's latest financial reports the company has a price-to-book ratio of 13.7.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Prometheus Biosciences - P/B ratio (from 2021 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 7.56 | 15.54% |
| 2021-12-31 | 6.55 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -9.38 | -168.45% | 🇺🇸 USA |
 Agenus
AGEN | -1.05 | -107.64% | 🇺🇸 USA |